Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer
AssigneePierre Fabre Medicament
InventorsPierre Fabre, Jean-Pierre Raynaud, Henri Cousse
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a lipido-sterolic Serenoa repens extract for the production of a medicament which is administered in an isolated manner or in an associated manner, in a simultaneous, separated or staggered manner, with prostatectomy, radiotherapy and/or hormonotherapy in order to prevent and/or treat prostate cancer.
Claims6
A method of treating a living human body afflicted with prostate cancer by administering a lipid-sterol extract of Serenoa Repens alone or in combination, simultaneously, separately or sequentially over time, with a prostatectomy, radiotherapy and/or a hormone therapy, for reduction of risk to develop prostate cancer and or treatment of prostate cancer.
Dependencies are inferred from the claim text.